Eli Lillys orforglipron, however, would be the first next-generation GLP-1 pill for weight loss if approved
However, because tirzepatide is generally more potent, even small amounts can have a physiological effect
Download Company Brochure (PDF) This analysis is based on publicly available data and manufacturer-provided information as of May 2026
Last reviewed: June 2, 2026 Last updated: June 2, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data
Some people find certain sites less sensitive or painful than others, and others notice a difference in side effects, depending on the site they choose